Skip to main content
. 2019 Aug 14;85(17):e01006-19. doi: 10.1128/AEM.01006-19

FIG 4.

FIG 4

Overlays of the PE fluorescence distributions of S. aureus exposed to various physical or chemical treatments (for an explanation of the labels, see Fig. 1) and stained with one of a pair of commercial anti-S. aureus antibodies, followed by staining with R-PE-conjugated secondary antibody. The left panel shows the average MFI/MFI(us) PE fluorescence values for the various treatments for both pairs of strains and antibodies.